Document is current
Any future updates will be listed below
-
Authors
Gómez-Abenza, Elena
Ibáñez-Molero, Sofía
García-Moreno, Diana
Fuentes, Inmaculada
Zon, Leonard I.
Mione, Maria C.
Cayuela, María L.
Gabellini, Chiara
Mulero, Victoriano https://orcid.org/0000-0001-9527-0211
-
Funding
Funding for this research was provided by:
Ministerio de Ciencia, Innovación y Universidades (BIO2014-52655-R)
Ministerio de Ciencia, Innovación y Universidades (BIO2017-84702-R, PI13/0234)
Fundación Séneca (19400/PI/14)
Seventh Framework Programme (FP7/2007-2013)
- License Information
-
More Information
Article History
Received: 30 July 2019
Accepted: 23 August 2019
First Online: 13 September 2019
Ethics approval and consent to participate
: The experiments complied with the Guidelines of the European Union Council (Directive 2010/63/EU) and the Spanish RD 53/2013. Experiments and procedures were performed as approved by the Consejería de Agua, Agricultura, Ganadería y Pesca de la CARM (authorization number # A13180602).
: Not applicable.
: L.I.Z. is a founder and stockholder of Fate Therapeutics, Inc., Scholar Rock and Camp4 Therapeutics.
